Journal
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Publication Date
2017
Volume
8
Inclusive Pages
156-164
Document Type
Open Access Publication
DOI
10.1016/j.dadm.2017.05.006
Rights and Permissions
Harrington KD, Lim YY, Ames D, et al (2017) Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 8:156-164. DOI: http://dx.doi.org/10.1016/j.dadm.2017.05.006 Copyright 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Harrington, Karra D.; Lim, Yen Ying; Ames, David; Hassenstab, Jason; Laws, Simon M.; Martins, Ralph N.; Rainey-Smith, Stephanie; Robertson, Joanne; Rowe, Christopher C.; Salvado, Olivier; Dore, Vincent; Villemagne, Victor L.; Snyder, Peter J.; Masters, Colin L.; and Maruff, Paul, "Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness." Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 8, 156-164. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6005
